RARE smart money
Ultragenyx Pharmaceutical In (RARE): 3 Congress trades, 5 top funds holding it, 2 ETF changes in the public filings.
Congress buys / sells3 / 0
Congress trades
| Filed | Member | Trade | Amount | Traded |
|---|---|---|---|---|
| 2026-10-12 | Gilbert Cisneros | Buy | $1k–$15k | 2026-09-29 |
| 2026-04-07 | Gilbert Cisneros | Buy | $1k–$15k | 2026-03-03 |
| 2026-03-09 | Gilbert Cisneros | Buy | $1k–$15k | 2026-02-18 |
Top 100 funds holding it
| # | Fund | Change | Weight | Value |
|---|---|---|---|---|
| 17 | Madison Avenue Partners, LP | BUY | 1.02% | $26M |
| 46 | Sofinnova Investments, INC. | 1.30% | $26M | |
| 51 | Dafna Capital Management LLC | ADD +8% | 0.16% | $800k |
| 72 | Sphera Funds Management LTD. | TRIM -42% | 0.77% | $5M |
| 86 | Adar1 Capital Management, LLC | BUY | 0.21% | $4M |
ETF changes
| ETF | Change | Value | Report |
|---|---|---|---|
| State Street(R) Spdr(R) S&p(R) Biotech ETF | ADD | +$19M | 2026-06-30 |
| Ishares U.S. Healthcare ETF | SELL | −$1M | 2026-07-31 |